WFDC2 and lung cancer: The SROC has been recommended to assess the performance of a diagnostic test in a meta-analysis.[39] Our meta-analysis found that the AUC of the SROC was 0.86 (95% CI 0.83–0.89), also demonstrating that HE4 was a potential biomarker for lung cancer diagnosis.